Drugmaker Pfizer's CEO Read to leave in January

phys.org | 10/1/2018 | Staff
just-mejust-me (Posted by) Level 3
Click For Photo: https://3c1703fe8d.site.internapcdn.net/newman/gfx/news/2018/drugmakerpfi.jpg

The biggest U.S.-based drugmaker will change leaders in January when Pfizer Chief Operating Officer Albert Bourla replaces CEO Ian Read, who has led the company for nearly eight years.

Pfizer said Monday that Read will become executive chairman of Pfizer's board of directors.

Maker - Viagra - Breast - Cancer - Drug

The maker of Viagra and the advanced breast cancer drug Ibrance has been dealing with shifting risks from the loss of patent protections for key products, like other drugmakers. For Pfizer, those drugs include the cholesterol pill Lipitor.

The New York company said in July that it was reshaping its business into three units: Innovative Medicines; Established Medicines, which handles older drugs that have lost protection; and Consumer Healthcare. It said Innovative Medicines will bring in most of the company's revenue and has strong growth potential due partially to an aging population...
(Excerpt) Read more at: phys.org
Wake Up To Breaking News!
Sign In or Register to comment.

Welcome to Long Room!

Where The World Finds Its News!